Increased risk of antiphospholipid syndrome in patients with psoriasis: a retrospective cohort study
Psoriasis and psoriatic arthritis are significant risk factors for APS, highlighting the need for targeted screening and management strategies in these populations.
Authors
- Shengming Dai (ORCID: https://orcid.org/0000-0001-7398-3165)
- Yu‐Hsun Wang (ORCID: https://orcid.org/0000-0002-4937-6119)
- Qian Wang (ORCID: https://orcid.org/0000-0003-4212-8486)
- Yu Du (ORCID: https://orcid.org/0000-0001-7342-0653)
- James Cheng-Chung Wei
- Ran Cui (ORCID: https://orcid.org/0000-0001-5414-0277)
Institutions
- China Medical University (TW)
- Chung Shan Medical University Hospital (TW)
- Shanghai Sixth People's Hospital (CN)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.3389/fimmu.2025.1620768
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00